Skip to main content

Table 1 Comparison of clinical characteristics

From: Usefulness of hemoglobin A1c and glycated albumin measurements for insulinoma screening: an observational case-control study

 

Insulinoma group (n = 31)

Control group (n = 120)

P value

Male gender, n (%)

10 (32.3)

36 (30.0)

0.808

Age, years

58.3 ± 19.7

57.3 ± 3.0

0.608

BMI, kg/m2

24.4 ± 4.3

23.9 ± 2.2

0.390

FPG, mg/dL

51.3 ± 15.3

93.0 ± 6.2

< 0.001

Fasting IRI, μU/mL

17.0 ± 16.3

4.6 ± 2.1

< 0.001

Fasting IRI/FPG

0.380 ± 0.433

0.050 ± 0.022

< 0.001

HbA1c, %

4.7 ± 0.4

5.7 ± 0.3

< 0.001

GA, %

11.6 ± 1.8

14.5 ± 1.0

< 0.001

  1. Data are mean ± SD. BMI, body mass index; FPG, fasting plasma glucose; HbA1c, hemoglobin A1c; GA, glycate d albumin. P values are for differences between two groups